The February 2017 edition of the Transplant Trial watch is now available.
This month, studies include novel monoclonal antibodies for prevention of CMV viraemia post-transplant, diagnostic markers for acute kidney rejection and chronic kidney injury, and portocaval shunts in liver transplantation.